Hormone blocker trial aims to unlock secrets of cervical mucus
NCT ID NCT07111247
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how a hormone-blocking drug called Relugolix affects cervical mucus in healthy women. Fifteen participants will take the drug for 10 days, and researchers will collect samples of blood, mucus, and tissue at different times. The goal is to better understand how mucus changes during the menstrual cycle, which could help with fertility or contraception research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Relugolix (a hormone blocker)
What this could lead to
If successful, this could improve understanding of cervical mucus, potentially aiding fertility or contraception research.
What could go wrong
This is a very small, early-phase study with only 15 participants, so results may not apply broadly. It is designed to gather knowledge, not to test a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL MUCUS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Oregon Health & Science University
RECRUITINGPortland, Oregon, 97239, United States
Contact